Literature DB >> 27806630

Deregulated miRNAs in human cervical cancer: functional importance and potential clinical use.

Jing Li1, Qiuli Liu2, Leslie H Clark3, Haifeng Qiu4, Victoria L Bae-Jump3,5, Chunxiao Zhou3,5.   

Abstract

Cervical cancer (CC) is one of the most common malignancies affecting women worldwide. While the morbidity and mortality associated with CC are decreasing in western countries, they both remain high in developing countries. Unfortunately, many issues about molecular mechanisms of CC are not clear yet. miRNAs are a group of small noncoding RNAs that could post-transcriptionally modulate the expression of specific genes and participate in the initiation and progression of multiple diseases including CC. In the last decade, mounting evidences suggest an association between miRNAs and human papillomavirus infection, as well as variations in biologic behavior, treatment response and prognosis in CC. Herein, we highlight the latest findings in this area and the potential applications.

Entities:  

Keywords:  HPV infection; cervical cancer; miRNA; prognosis; susceptibility

Mesh:

Substances:

Year:  2016        PMID: 27806630     DOI: 10.2217/fon-2016-0328

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  15 in total

Review 1.  HPV epigenetic mechanisms related to Oropharyngeal and Cervix cancers.

Authors:  Marina Di Domenico; Giancarlo Giovane; Soumaya Kouidhi; Rosamaria Iorio; Maurizio Romano; Francesco De Francesco; Antonia Feola; Camilla Siciliano; Luigi Califano; Antonio Giordano
Journal:  Cancer Biol Ther       Date:  2018-05-14       Impact factor: 4.742

2.  Diagnostic and prognostic value of microRNA-628 for cancers.

Authors:  Jing-Hua Li; Shan-Shan Sun; Chang-Jin Fu; An-Qi Zhang; Chen Wang; Rong Xu; Shu-Yang Xie; Ping-Yu Wang
Journal:  J Cancer       Date:  2018-04-12       Impact factor: 4.207

3.  miR-139-5p functions as a tumor suppressor in cervical cancer by targeting TCF4 and inhibiting Wnt/β-catenin signaling.

Authors:  Xia Ji; Hairong Guo; Shanyu Yin; Haiyan Du
Journal:  Onco Targets Ther       Date:  2019-09-20       Impact factor: 4.147

4.  DANCR-mediated microRNA-665 regulates proliferation and metastasis of cervical cancer through the ERK/SMAD pathway.

Authors:  Liyan Cao; Haihong Jin; Yue Zheng; Yu Mao; Zhanzhao Fu; Xin Li; Lixin Dong
Journal:  Cancer Sci       Date:  2019-01-19       Impact factor: 6.716

5.  MicroRNA-505-5p functions as a tumor suppressor by targeting cyclin-dependent kinase 5 in cervical cancer.

Authors:  Elena Kapora; Shujun Feng; Wei Liu; Indira Sakhautdinova; Bo Gao; Wenhua Tan
Journal:  Biosci Rep       Date:  2019-07-25       Impact factor: 3.840

6.  Polymorphisms in miRNA genes play roles in the initiation and development of cervical cancer.

Authors:  Zhiling Yan; Ziyun Zhou; Chuanyin Li; Xielang Yang; Longyu Yang; Shuying Dai; Jiehan Zhao; Huijing Ni; Li Shi; Yufeng Yao
Journal:  J Cancer       Date:  2019-08-20       Impact factor: 4.207

7.  MicroRNA-143 Sensitizes Cervical Cancer Cells to Cisplatin: a Promising Anticancer Combination Therapy.

Authors:  Yalda Baghay Esfandyari; Mohammad Amin Doustvandi; Mohammad Amini; Behzad Baradaran; Sheyda Jodeiry Zaer; Nazila Mozammel; Mehdi Mohammadzadeh; Ahad Mokhtarzadeh
Journal:  Reprod Sci       Date:  2021-02-10       Impact factor: 3.060

8.  Up-regulation of inflammation-related LncRNA-IL7R predicts poor clinical outcome in patients with cervical cancer.

Authors:  Yangyang Fan; Yan Nan; Juanjuan Huang; Hui Zhong; Weidong Zhou
Journal:  Biosci Rep       Date:  2018-06-12       Impact factor: 3.840

9.  MicroRNA-92a promotes tumor growth and suppresses immune function through activation of MAPK/ERK signaling pathway by inhibiting PTEN in mice bearing U14 cervical cancer.

Authors:  Zeng-Hui Li; Lei Li; Lin-Ping Kang; Yan Wang
Journal:  Cancer Med       Date:  2018-05-11       Impact factor: 4.452

10.  A novel miRNA identified in GRSF1 complex drives the metastasis via the PIK3R3/AKT/NF-κB and TIMP3/MMP9 pathways in cervical cancer cells.

Authors:  Qi Sun; Zhen Yang; Pu Li; Xu Wang; Lu Sun; Shixing Wang; Min Liu; Hua Tang
Journal:  Cell Death Dis       Date:  2019-09-02       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.